Insmed (INSM) Cash from Financing Activities (2010 - 2026)

Insmed's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $29.5 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 1.78% year-over-year to $29.5 million; the TTM figure through Mar 2026 stood at $954.6 million (down 30.17% YoY), while the FY2025 annual figure was $954.1 million, down 28.85% from the prior year.
• Cash from Financing Activities was $29.5 million for Q1 2026 at Insmed, down from $33.9 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $857.8 million in Q2 2025 to a low of -$399000.0 in Q1 2023.
• Historically, Cash from Financing Activities has averaged $193.3 million across 5 years, with a median of $33.9 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities sank 106.18% in 2023, then surged 31701.44% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at $743.4 million in 2022, then sank by 83.42% to $123.3 million in 2023, then gained by 29.24% to $159.3 million in 2024, then tumbled by 78.75% to $33.9 million in 2025, then slipped by 12.83% to $29.5 million in 2026.
• The last three Cash from Financing Activities figures came in at $29.5 million (Q1 2026), $33.9 million (Q4 2025), and $33.4 million (Q3 2025), per Business Quant data.